Free Trial

Forte Biosciences (FBRX) Insider Trading & Ownership

Forte Biosciences logo
$19.70 +0.69 (+3.63%)
(As of 01:00 PM ET)

Forte Biosciences (NASDAQ:FBRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
9.60%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$124,952.70
Number Of
Insiders Selling
(Last 12 Months)
0
Get FBRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Forte Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

FBRX Insider Buying and Selling by Quarter

Forte Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/21/2024Antony A RileyCFOBuy22,514$5.55$124,952.70  
(Data available from 1/1/2013 forward)

FBRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Forte Biosciences includes Antony A Riley, and Paul A Wagner. Learn more on insiders at FBRX.

9.60% of Forte Biosciences stock is owned by insiders. Learn more on FBRX's insider holdings.

The following insiders have purchased FBRX shares in the last 24 months: Antony A Riley ($124,952.70), and Paul A Wagner ($55,348.78).

Insiders have purchased a total of 111,603 FBRX shares in the last 24 months for a total of $180,301.48 bought.

Forte Biosciences Key Executives

  • Dr. Paul A. Wagner Ph.D. (Age 54)
    CEO, President & Chairman
    Compensation: $960.23k
  • Mr. Antony A. Riley CPA (Age 57)
    Chief Financial Officer
    Compensation: $568.48k
    1 recent trades
  • Dr. Barbara K. Finck M.D. (Age 77)
    Chief Medical Clinician & Director
    Compensation: $45k
  • Mr. Christopher Roenfeldt
    Chief Operating Officer
  • Mr. Steven Ruhl (Age 67)
    Chief Technical Officer


This page (NASDAQ:FBRX) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners